AlphAIAlphAI — Financial news for AI agents
tradingview.com$AFYA

Afya Limited (AFYA) Q3 Revenue Rises 6.1% to R$985.2M

Afya Limited reported Q3 2026 revenue of R$985.2M, up 6.1% YoY, and Adjusted EBITDA of R$433.8M, up 8.7%. Nine-month net income rose 6.9% to R$634.0M. The company reaffirmed its full-year 2026 guidance. The next catalysts are shareholder and regulatory decisions on its proposed merger with Yduqs.

Original reporting
tradingview.com
Published Nov 12, 2026, 11:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 11:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Afya Limited (AFYA) Q3 Revenue Rises 6.1% to R$985.2M — source image
Source · tradingview.com
Decision brief

The 30-second read

$AFYABullishMed
01

Why it matters

The earnings release provides fresh data that could influence investor positioning in Afya and related education stocks.

02

Market read

First‑report earnings data with modest growth, likely to affect Afya's share price and sector sentiment.

03

What to watch

Currency fluctuations and upcoming merger with Yduqs could introduce execution risk.

Relevance 7/10Novelty 7/10Timing: after-hours

Background

Afya Limited reported its Q3 2026 financial results, showing revenue and EBITDA growth and reaffirming its full‑year outlook amid a pending merger with Yduqs.

Company-level read

Ticker impact

$AFYABullishHigh confidence
Context

Q3 2026 revenue rose 6.1% YoY to R$985.2M and adjusted EBITDA grew 8.7% while reaffirming full‑year guidance.

Expected impact

potential modest upside as market prices in growth and reaffirmed guidance

Evidence & confidence

Strong top‑line growth and guidance reaffirmation typically support the stock price.

Market effects

Sector

Positive earnings may lift the Brazilian education sector.

Regional

Supports broader sentiment on Brazil's corporate earnings.

Global

Limited to investors focused on emerging‑market education stocks.

Counterpoint

What could challenge this read

If the market had already priced in growth, the reaffirmed guidance may not move the stock.

Key entities

  • Company
    Afya Limited

    Brazilian education services provider listed on NYSE under AFYA.

  • Company
    Yduqs

    Potential merger partner for Afya.

Read at source← All news

Related articles

$AFYAHigh

Afya Ltd (AFYA): Financial results for Q3 2026

Afya Ltd (AFYA) furnished an SEC Form 6-K — earnings release. Afya Limited Announces Third Quarter and Nine Months 2026 Financial Results Strong Cash Conversion and Continued Earnings Growth Full-Year 2026 Guidance Reaffirmed Belo Horizonte, Brazil, November 12, 2026 – Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the l

SEC EDGAR 6-K
$AFYAHigh

BofA upgrades Afya stock rating on exam rule changes

BofA upgraded Afya (AFYA) to Buy, lowering its price target to $16. The firm cited Afya's resilient student base, low leverage, and recent exam rule changes as reasons. Afya trades at $10.24, near its 52-week low, with a 6.32 P/E ratio and 30% free cash flow yield. Afya reported 6% Q2 and 7% H1 revenue growth, with net income rising 14% and 7% respectively. JPMorgan also upgraded Afya to Overweight, expecting merger synergies.

investing.com
$AFYAHigh

JPMorgan upgrades Afya stock rating on merger synergies

JPMorgan upgraded Afya Ltd. (AFYA) to Overweight, citing merger synergies of R$1.8 billion and a premium higher education company. The price target was lowered to $19.00 from $21.00. Afya reported Q2 2026 revenue growth of 6% and H1 growth of 7%, with net income rising 14% in Q2 and 7% in H1. The company trades at a P/E ratio of 8 and a 23% free cash flow yield.

investing.com